However, we still do not have a full understanding of the nature of ORAI1 overexpression in breast cancer molecular subtypes nor the possible drivers for altered expression, such as is evident in the overexpression of TRPV6 in ERα-negative breast cancers, which is associated with increases in gene copy number [13]. The gene discussed is ORAI1; the disease is breast cancer.